Tissue-wide metabolic buffering confers resilience to mitochondrial dysfunction
- 1University of Cambridge
Abstract
Mitochondria and oxidative phosphorylation (OxPhos) are essential for cellular homeostasis. However, the phenotypes caused by mitochondrial dysfunction often display remarkable tissue-specificity. What determines the susceptibility of individual cells to metabolic or mitochondrial defects in a complex in vivo tissue context, remains largely unknown. We find that neural stem cells (NSCs) in the developing Drosophila brain can maintain normal proliferation despite severe cell-autonomous OxPhos-dysfunction, provided that sufficient neighbouring cells remain metabolically intact. This tissue-wide buffering progressively fails as the proportion of NSCs with OxPhos dysfunction increases, indicating that the phenotypic threshold for mitochondrial dysfunction is an emergent property of a tissue rather than only of individual cells or cell-types. Mechanistically, we find that OxPhos-deficient NSCs activate a stress-response associated with ATF4/crc-transcriptional activation. NSCs upregulate lactate dehydrogenase (LDH) expression to maintain glycolysis, but their proliferation remains limited by NAD+ regeneration rather than by ATP production. Non-cell-autonomous rescue of NSC-proliferation depends on LDH-dependent NAD+-production in a brain-wide glial network connected by gap junctions and the glutamate/aspartate-transporter Eaat1. These findings demonstrate that the phenotypic threshold for mitochondrial dysfunction is determined by tissue-wide spare metabolic capacity rather than only of individual cells or cell-types. Tissue heterogeneity thus provides resilience to metabolic dysfunction, evidencing key benefits of diversity, and suggesting new therapeutic strategies to enhance endogenous metabolic buffering.
Related
- Hyperhomocysteinemia and Klotho in kidney-to-brain signaling: a metabolic stress-resilience framework for neurovascular dysfunction
- A self-limiting, TREM2-dependent anabolic program confers microglial resilience in Alzheimer's disease
- Mitochondrial RNA as a broad-spectrum DAMP coordinates antiviral and damage-related immune clearance and confers therapeutic potential.
- IDO1 methylation by EZH2 confers resistance to its targeted therapy in colorectal cancer through tryptophan-kynurenine metabolic rewiring
- Mitochondrial NAD+ import gates neuronal resilience to active SARM1
BibTeX
@misc{petridi2026tissuewide,
title = {{Tissue-wide metabolic buffering confers resilience to mitochondrial dysfunction}},
author = {S. Petridi and A. Dhawanjewar and D. Dubal and R. Chandrasegaram and H. Dickmänken and N. Bala-Muraly and B. A. Wilson and T. Eve and B. Marzullo and A. Hynes-Allen and S. A. Jones and M. S. King and R. Butler and M. Sciacovelli and E. R. S. Kunji and D. A. Tennant and J. van den Ameele},
howpublished = {bioRxiv},
year = {2026},
month = aug,
doi = {10.64898/2026.08.27.747448},
url = {https://www.biorxiv.org/content/10.64898/2026.08.27.747448v2},
note = {CC BY},
}
RIS
TY - UNPB
TI - Tissue-wide metabolic buffering confers resilience to mitochondrial dysfunction
AU - S. Petridi
AU - A. Dhawanjewar
AU - D. Dubal
AU - R. Chandrasegaram
AU - H. Dickmänken
AU - N. Bala-Muraly
AU - B. A. Wilson
AU - T. Eve
AU - B. Marzullo
AU - A. Hynes-Allen
AU - S. A. Jones
AU - M. S. King
AU - R. Butler
AU - M. Sciacovelli
AU - E. R. S. Kunji
AU - D. A. Tennant
AU - J. van den Ameele
PY - 2026
DA - 2026/08/27
PB - bioRxiv
DO - 10.64898/2026.08.27.747448
UR - https://www.biorxiv.org/content/10.64898/2026.08.27.747448v2
AB - Mitochondria and oxidative phosphorylation (OxPhos) are essential for cellular homeostasis. However, the phenotypes caused by mitochondrial dysfunction often display remarkable tissue-specificity. What determines the susceptibility of individual cells to metabolic or mitochondrial defects in a complex in vivo tissue context, remains largely unknown. We find that neural stem cells (NSCs) in the developing Drosophila brain can maintain normal proliferation despite severe cell-autonomous OxPhos-dysfunction, provided that sufficient neighbouring cells remain metabolically intact. This tissue-wide buffering progressively fails as the proportion of NSCs with OxPhos dysfunction increases, indicating that the phenotypic threshold for mitochondrial dysfunction is an emergent property of a tissue rather than only of individual cells or cell-types. Mechanistically, we find that OxPhos-deficient NSCs activate a stress-response associated with ATF4/crc-transcriptional activation. NSCs upregulate lactate dehydrogenase (LDH) expression to maintain glycolysis, but their proliferation remains limited by NAD+ regeneration rather than by ATP production. Non-cell-autonomous rescue of NSC-proliferation depends on LDH-dependent NAD+-production in a brain-wide glial network connected by gap junctions and the glutamate/aspartate-transporter Eaat1. These findings demonstrate that the phenotypic threshold for mitochondrial dysfunction is determined by tissue-wide spare metabolic capacity rather than only of individual cells or cell-types. Tissue heterogeneity thus provides resilience to metabolic dysfunction, evidencing key benefits of diversity, and suggesting new therapeutic strategies to enhance endogenous metabolic buffering.
ER -